TORONTO, March 20,
2024 /CNW/ - Neighbourly Pharmacy Inc.
("Neighbourly" or the "Company") (TSX: NBLY),
Canada's largest and fastest
growing network of independent pharmacies, is pleased to announce
the closing of the previously announced plan of arrangement (the
"Transaction") to be taken private by Persistence Capital
Partners ("PCP").
"Today's announcement marks an important milestone for
Neighbourly. We are excited for a bright future as a private
company," said Skip Bourdo, Chief
Executive Officer of Neighbourly. "This going-private transaction
provides us with increased flexibility to pursue our growth
initiatives, invest in innovation, and drive operational
excellence. We are focused on continuing to grow our network of
pharmacies and serve more communities across Canada."
"I would like to express my gratitude to our shareholders for
their overwhelming support throughout this journey. We are excited
about continuing to work closely with Neighbourly to accelerate its
growth and achieve its strategic vision - to advance the role that
independent pharmacies can play across Canada, creating value for customers,
patients, employees, and partners," said Stuart M. Elman, Managing Partner of PCP.
"Brookfield is pleased to
provide flexible and strategic capital to Neighbourly and PCP. We
look forward to partnering with the Company as it continues to grow
and deliver high quality healthcare services to Canadian
communities," commented Michael
Horowitz, Managing Director, Brookfield and Brookfield Special Investments
("BSI").
The Transaction received overwhelming support from the Company's
shareholders at a special meeting held on March 8, 2024, and the Transaction received final
court approval on March 13, 2024.
As a result of the Transaction, the Common Shares are expected
to be delisted from the Toronto Stock Exchange ("TSX") at
the close of trading on or about March 21,
2024. The Company has submitted an application to cease to
be a reporting issuer under applicable Canadian securities laws and
to otherwise terminate the Company's public reporting
requirements.
Advisors
Scotiabank and RBC Capital Markets acted as financial advisors
to PCP, and Stikeman Elliott LLP acted as legal advisor to PCP.
Devon Park Advisors1 provided strategic advisory and
capital raising services to PCP.
TD Securities acted as financial advisor and independent
valuator to the transaction committee of the Company, and McCarthy
Tétrault LLP acted as independent legal advisor to the transaction
committee of the Company.
Goodmans LLP acted as legal advisor to BSI.
___________________________
|
1
INTE Securities LLC dba Devon Park Advisors is a member of FINRA
(www.finra.org) / SIPC (www.sipc.org). To view INTE Securities LLC,
please go to www.finra.org/brokercheck.
|
About Neighbourly Pharmacy
Inc.
Neighbourly is Canada's largest
and fastest growing network of community
pharmacies. United by their patient first focus and their
role as essential and trusted healthcare hubs within their
communities, Neighbourly's pharmacies strive to provide
accessible healthcare with a personal touch. Since 2015,
Neighbourly has expanded its diversified national
footprint to include 294 locations, reinforcing the
Company's reputation as the industry's acquirer of choice.
About Persistence Capital
Partners
Persistence Capital Partners is Canada's leading private equity fund
exclusively focused on high-growth opportunities in the healthcare
field. With deep healthcare industry expertise, PCP aims to create
significant long-term capital appreciation for its investors by
identifying and developing attractive investment opportunities in
the healthcare market.
About Brookfield
Brookfield Asset Management (NYSE: BAM, TSX: BAM) is a leading
global alternative asset manager with over $900 billion of assets under management across
renewable power and transition, infrastructure, private equity,
real estate, and credit. We invest client capital for the long-term
with a focus on real assets and essential service businesses that
form the backbone of the global economy. We offer a range of
alternative investment products to investors around the world —
including public and private pension plans, endowments and
foundations, sovereign wealth funds, financial institutions,
insurance companies and private wealth investors. We draw on
Brookfield's heritage as an owner
and operator to invest for value and generate strong returns for
our clients, across economic cycles. For more information, please
visit our website at www.bam.brookfield.com.
Forward Looking
Information
This news release contains "forward-looking information"
and "forward-looking statements" (collectively, "forward-looking
information") within the meaning of applicable securities laws.
This information includes, but is not limited to, statements
concerning the timing of the delisting of the Common Shares on the
TSX, the cessation of the Company's reporting issuer status, and
other statements that are not material facts. In some cases,
forward-looking information can be identified by the use of
forward-looking terminology such as "expects", "estimates",
"outlook", "forecasts", "projection", "prospects", "intends",
"anticipates", "believes", or variations of such words and phrases
or statements that certain actions, events or results "may",
"could", "would", "might", "will", "will be taken", "occur" or "be
achieved". In addition, any statements that refer to expectations,
intentions, projections or other characterizations of future
events or circumstances contain forward-looking information.
Statements containing forward-looking information are not
historical facts but instead represent management's expectations,
estimates and projections regarding future events or
circumstances. Forward-looking information in this news release
include, among other things, statements relating to Neighbourly's
business in general, the achievement of the CVR EBITDA Target and
the payout of additional amounts to holders of CVRs under the
Transaction, the delisting of the Common Shares on the TSX and the
application to cease to be a reporting issuer.
Risks and uncertainties related to the Transaction include, but
are not limited to: the possibility that the Common Shares will not
be delisted from the TSX in accordance with the timing currently
contemplated, and that the Common Shares may not be delisted at
all, due to a failure to satisfy, in a timely manner or otherwise,
conditions necessary to delist the Common Shares from the TSX or
for other reasons.
Although we have attempted to identify important risk factors
that could cause actual results to differ materially from those
contained in forward-looking information, there may be other risk
factors not presently known to us or that we presently believe are
not material that could also cause actual results or future events
to differ materially from those expressed in such forward-looking
information. There can be no assurance that such information will
prove to be accurate, as actual results and future events could
differ materially from those anticipated in such information. No
forward-looking statement is a guarantee of future results.
Accordingly, you should not place undue reliance on forward-looking
information, which speaks only as of the date made. The
forward-looking information contained in this news release
represents the Company's expectations as of the date of this news
release (or as the date they are otherwise stated to be made) and
are subject to change after such date. However, the Company
disclaims any intention or obligation or undertaking to update or
revise any forward-looking information whether as a result of new
information, future events or otherwise, except as required under
applicable securities laws in Canada. All of the forward-looking information
contained in this news release is expressly qualified by the
foregoing cautionary statements.
This announcement is for informational purposes only and does
not constitute an offer to purchase or a solicitation of an offer
to sell, or an offer to sell or a solicitation of an offer to buy,
Neighbourly Common Shares.
SOURCE Neighbourly Pharmacy Inc.